Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB · BSE: 532305 · Pharmaceuticals & Biotechnology · 39 announcements

Share price
₹391.00
Market cap
₹3,400 Cr
Revenue (annual)
₹641.3 Cr
Net profit (annual)
₹41.42 Cr
P/E (TTM)
59.3×Sector 47.4×
Promoter holding
42.93%-0.06% QoQ
FII holding
10.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:44 IST BSE
Annual General Meeting

Ind-Swift Laboratories Annual General Meeting

Ind-Swift Laboratories Ltd will hold its 31st Annual General Meeting on September 30, 2026, via video conference. The agenda includes financial adoption and director appointments.

15:44 IST BSE
Annual General Meeting

Ind-Swift Laboratories Annual General Meeting

Ind-Swift Laboratories disclosed voting results of its EGM held on August 5, 2026, where resolutions including warrant issuance were approved by shareholders.

17:45 IST BSE
Annual General Meeting

Ind-Swift Laboratories Annual General Meeting

Ind-Swift Laboratories issued a corrigendum to its EGM notice for the proposed preferential issue of fully convertible warrants, following queries from stock exchanges.

20:36 IST BSE
Annual General Meeting

Ind-Swift Laboratories Annual General Meeting

Ind-Swift Laboratories convened an EGM for August 5, 2026. Key agendas include issuing 70 lakh convertible warrants to promoters and re-appointing an Independent Director.

19:44 IST NSE
Annual General Meeting

Ind-Swift Laboratories Annual General Meeting

Ind-Swift Laboratories convened an EGM for August 05, 2026. Agenda includes a Rs. 137.20 Crore preferential warrant issuance to promoter entity Essix Biosciences.

Value
₹137.2 Cr
19:00 IST NSE
Annual General Meeting

Ind-Swift Laboratories Annual General Meeting

Ind-Swift Laboratories Limited announced the successful passage of four special resolutions via postal ballot. Shareholders approved the redesignation of Sh. N.R. Munjal and the appointments of Sh. Himanshu Jain and Sh. Sahil Munjal as Managing Directors. Additionally, the payment of remuneration to Whole-Time Director Sh. Rishav Mehta was approved with a requisite majority.